Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis

NCT00001646 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
Aspergillosis
HIV Infections
Immunologic Deficiency Syndromes
Neutropenia

Interventions

DRUG: Voriconazole
DRUG: Amphotericin B

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)